Compass Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/14/2025 | 22.36 M | $32.43 M | 0.00% | 16.25% |
| BLACKSTONE INC. | 02/14/2025 | 10.03 M | $14.54 M | 0.00% | 7.29% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 8.57 M | $12.42 M | 51.86% | 6.23% |
| 02/14/2025 | 7.79 M | $11.29 M | 100.00% | 5.66% | |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 6.89 M | $9.99 M | 0.98% | 5.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 5.99 M | $8.69 M | -46.14% | 4.36% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 5.90 M | $8.56 M | 225.43% | 4.29% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 5.78 M | $8.38 M | 2.67% | 4.20% |
| VANGUARD GROUP INC | 02/11/2025 | 4.72 M | $6.84 M | 10.16% | 3.43% |
| FMR LLC | 02/13/2025 | 4.14 M | $6.00 M | 0.00% | 3.01% |
| VIVO CAPITAL, LLC | 02/13/2025 | 3.56 M | $5.16 M | 0.00% | 2.58% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 2.95 M | $4.28 M | 2.60% | 2.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.33 M | $3.39 M | 1.06% | 1.70% |
| STATE STREET CORP | 02/14/2025 | 1.90 M | $2.76 M | 2.09% | 1.38% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 1.56 M | $2.26 M | 0.00% | 1.13% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/14/2025 | 448,164 | $649,838 | -10.37% | 0.33% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 390,439 | $566,137 | 5.20% | 0.28% |
| CM MANAGEMENT, LLC | 02/07/2025 | 310,000 | $449,500 | 0.00% | 0.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 304,504 | $441,531 | 0.00% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 286,191 | $414,977 | 0.00% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 278,600 | $403,970 | 25.16% | 0.20% |
| JPMORGAN CHASE & CO | 02/12/2025 | 272,328 | $394,875 | 512.47% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 237,975 | $345,064 | 2.60% | 0.17% |
| BARCLAYS PLC | 02/13/2025 | 192,766 | $279,000 | 13.23% | 0.14% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 171,466 | $248,626 | 21.08% | 0.12% |
| UBS GROUP AG | 02/14/2025 | 163,656 | $237,302 | 150.24% | 0.12% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 158,394 | $229,671 | 35.52% | 0.12% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 156,871 | $227,463 | -32.40% | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 145,238 | $210,595 | -24.85% | 0.11% |
| RHUMBLINE ADVISERS | 01/30/2025 | 129,116 | $187,209 | 3.05% | 0.09% |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 100,000 | $145,000 | -44.44% | 0.07% |
| EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 97,931 | $142,000 | 0.00% | 0.07% |
| CITIGROUP INC | 02/12/2025 | 78,603 | $113,975 | 5.82% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 63,141 | $91,554 | 200.30% | 0.05% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 59,860 | $86,797 | 27.85% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 58,466 | $84,776 | 4.48% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 54,615 | $79,192 | 51.55% | 0.04% |
| XTX TOPCO LTD | 02/13/2025 | 52,754 | $76,493 | 160.89% | 0.04% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 51,924 | $75,290 | 218.71% | 0.04% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 51,000 | $73,950 | -40.97% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 50,704 | $73,521 | -7.02% | 0.04% |
| CATALINA CAPITAL GROUP, LLC | 01/24/2025 | 48,964 | $70,998 | 100.00% | 0.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 46,942 | $69,000 | 31.80% | 0.03% |
| CAXTON CORP | 02/14/2025 | 43,465 | $63,025 | 0.00% | 0.03% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 41,980 | $60,871 | -1.62% | 0.03% |
| BLEAKLEY FINANCIAL GROUP, LLC | 01/27/2025 | 39,993 | $57,990 | 250.69% | 0.03% |
| INVESCO LTD. | 02/13/2025 | 39,483 | $57,250 | 11.33% | 0.03% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 38,207 | $55,000 | 0.00% | 0.03% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 33,857 | $49,093 | -80.01% | 0.02% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 32,561 | $47,213 | -13.55% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Compass Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of Compass Therapeutics, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 22.36 M
Blackstone Inc.: 10.03 M
BioImpact Capital LLC: 8.57 M
BlackRock Funding, Inc. /DE: 6.89 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.99 M
TANG CAPITAL MANAGEMENT LLC: 5.9 M
73.67% of Compass Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 104.21 M shares in the last 24 months. This purchase volume represents approximately $164.65 M in transactions.